Show simple item record

dc.contributor.authorPickard, Mark R.*
dc.contributor.authorWilliams, Gwyn T.*
dc.date.accessioned2016-04-04T13:23:40Z
dc.date.available2016-04-04T13:23:40Z
dc.date.issued2016-02-03
dc.identifier.citationPickard, M. R., & Williams, G. T. (2016). The hormone response element mimic sequence of GAS5 lncRNA is sufficient to induce apoptosis in breast cancer cells. Oncotarget, 7(9), 10104-10116. https://doi.org/10.18632/oncotarget.7173
dc.identifier.pmid26862727
dc.identifier.doi10.18632/oncotarget.7173
dc.identifier.urihttp://hdl.handle.net/10034/604377
dc.description.abstractGrowth arrest-specific 5 (GAS5) lncRNA promotes apoptosis, and its expression is down-regulated in breast cancer. GAS5 lncRNA is a decoy of glucocorticoid/related receptors; a stem-loop sequence constitutes the GAS5 hormone response element mimic (HREM), which is essential for the regulation of breast cancer cell apoptosis. This preclinical study aimed to determine if the GAS5 HREM sequence alone promotes the apoptosis of breast cancer cells. Nucleofection of hormone-sensitive and -insensitive breast cancer cell lines with a GAS5 HREM DNA oligonucleotide increased both basal and ultraviolet-C-induced apoptosis, and decreased culture viability and clonogenic growth, similar to GAS5 lncRNA. The HREM oligonucleotide demonstrated similar sequence specificity to the native HREM for its functional activity and had no effect on endogenous GAS5 lncRNA levels. Certain chemically modified HREM oligonucleotides, notably DNA and RNA phosphorothioates, retained pro-apoptotic. activity. Crucially the HREM oligonucleotide could overcome apoptosis resistance secondary to deficient endogenous GAS5 lncRNA levels. Thus, the GAS5 lncRNA HREM sequence alone is sufficient to induce apoptosis in breast cancer cells, including triple-negative breast cancer cells. These findings further suggest that emerging knowledge of structure/function relationships in the field of lncRNA biology can be exploited for the development of entirely novel, oligonucleotide mimic-based, cancer therapies.
dc.description.sponsorshipBreast Cancer Now
dc.language.isoenen
dc.publisherImpact Journals
dc.relation.urlhttps://www.oncotarget.com/article/7173/text/en
dc.subjectapoptosisen
dc.subjectbreast canceren
dc.subjectlncRNAen
dc.subjectoligonucleotide therapyen
dc.subjectGAS5en
dc.titleThe hormone response element mimic sequence of GAS5 lncRNA is sufficient to induce apoptosis in breast cancer cells.en
dc.typeArticleen
dc.identifier.eissn1949-2553
dc.contributor.departmentKeele University
dc.identifier.journalOncotargeten
rioxxterms.versionofrecordhttp://doi.org/10.18632/oncotarget.7173
html.description.abstractGrowth arrest-specific 5 (GAS5) lncRNA promotes apoptosis, and its expression is down-regulated in breast cancer. GAS5 lncRNA is a decoy of glucocorticoid/related receptors; a stem-loop sequence constitutes the GAS5 hormone response element mimic (HREM), which is essential for the regulation of breast cancer cell apoptosis. This preclinical study aimed to determine if the GAS5 HREM sequence alone promotes the apoptosis of breast cancer cells. Nucleofection of hormone-sensitive and -insensitive breast cancer cell lines with a GAS5 HREM DNA oligonucleotide increased both basal and ultraviolet-C-induced apoptosis, and decreased culture viability and clonogenic growth, similar to GAS5 lncRNA. The HREM oligonucleotide demonstrated similar sequence specificity to the native HREM for its functional activity and had no effect on endogenous GAS5 lncRNA levels. Certain chemically modified HREM oligonucleotides, notably DNA and RNA phosphorothioates, retained pro-apoptotic. activity. Crucially the HREM oligonucleotide could overcome apoptosis resistance secondary to deficient endogenous GAS5 lncRNA levels. Thus, the GAS5 lncRNA HREM sequence alone is sufficient to induce apoptosis in breast cancer cells, including triple-negative breast cancer cells. These findings further suggest that emerging knowledge of structure/function relationships in the field of lncRNA biology can be exploited for the development of entirely novel, oligonucleotide mimic-based, cancer therapies.


Files in this item

Thumbnail
Name:
Pickard & Williams Oncotarget ...
Size:
2.201Mb
Format:
PDF
Request:
Article - VoR

This item appears in the following Collection(s)

Show simple item record